Using Magnetocardiography to Assess Chest Pain Risks

Magnetocardiography in the Identification and Risk Stratification of Patients With Acute Chest Pian

This study tests if a special heart scan can help doctors understand the risks of chest pain in people who might have a serious heart condition.

Quick facts

• Study type: Observational
• Enrollment: 3620 (estimated)
• Sex: All
• Sponsor: Qilu Hospital of Shandong University (Academic / other)
• Locations: 1 site (Jinan, Shandong)
• Trial ID: NCT06316011 on ClinicalTrials.gov

What this trial studies

This observational study aims to identify and stratify the risk of patients presenting with acute chest pain suspected of having acute coronary syndrome (ACS) using Magnetocardiography (MCG). The study will involve a prospective cohort of patients who meet specific inclusion criteria, including those with suspected ACS. Participants will undergo MCG examinations to evaluate their cardiac function and risk levels. The findings may help in better management and treatment decisions for patients with chest pain.

Who should consider this trial

Good fit: Ideal candidates for this study are individuals presenting with symptoms of acute chest pain suspected of acute coronary syndrome.

Not a fit: Patients with known structural heart disease, significant arrhythmias, or other critical conditions may not benefit from this study.

Why it matters

Potential benefit: If successful, this approach could lead to improved risk assessment and management of patients with acute chest pain, potentially reducing adverse outcomes.

How similar studies have performed: While the use of Magnetocardiography is a relatively novel approach, similar studies in cardiac risk assessment have shown promising results.

Eligibility criteria

Inclusion Criteria:

* Those with suspected ACS who presented with symptoms of acute chest pain.
* Signed informed consent.

Exclusion Criteria:

* Those with known structural heart disease such as cardiomyopathy and valvular disease;
* Those with atrial fibrillation, supraventricular tachycardia, atrioventricular block and other arrhythmias that have not returned to normal;
* Those who have chest pain with known pulmonary embolism or aortic coarctation;
* Those who are thought to be incapable of completing the MCG examination by an attending physician (or physician with higher qualifications) due to unstable clinical conditions, metal implants, etc;
* Those who are unable to perform magnetocardiography examinations due to claustrophobia, etc., or those who fail to receive magnetocardiography examination;
* Those with malignant tumors;
* Pregnant or lactating women.
* Those with acute or critical illnesses of other systems, such as acute or severe respiratory illnesses, marked abnormalities in liver function or kidney function.

Where this trial is running

Jinan, Shandong

• Qilu Hospital of Shandong University — Jinan, Shandong, China (Recruiting)

Study contacts

• Principal investigator: Yuguo Chen, Professor — Qliu Hospital of Shandong University
• Study coordinator: Jiaojiao Pang, Doctor

Conditions Acute Coronary Syndrome